These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25145873)

  • 21. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity of silver nanoparticles against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Shah AA; Ahmad I; Shafique M; Siddique AB; Aslam B; Qamar MU
    Pak J Pharm Sci; 2022 Jan; 35(1(Supplementary)):203-208. PubMed ID: 35228178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial Activities of Bacteriagenic Silver Nanoparticles Against Nosocomial
    Singh R; Vora J; Nadhe SB; Wadhwani SA; Shedbalkar UU; Chopade BA
    J Nanosci Nanotechnol; 2018 Jun; 18(6):3806-3815. PubMed ID: 29442713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
    Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
    Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria.
    Cavassin ED; de Figueiredo LF; Otoch JP; Seckler MM; de Oliveira RA; Franco FF; Marangoni VS; Zucolotto V; Levin AS; Costa SF
    J Nanobiotechnology; 2015 Oct; 13():64. PubMed ID: 26438142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.
    Tognim MC; Andrade SS; Silbert S; Gales AC; Jones RN; Sader HS
    Int J Infect Dis; 2004 Sep; 8(5):284-91. PubMed ID: 15325597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.
    Eser OK; Ergin A; Tunçkanat F; Hasçelik G
    New Microbiol; 2008 Oct; 31(4):535-42. PubMed ID: 19123310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
    Sader HS; Jones RN
    Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biogenic silver nanoparticle (Bio-AgNP) has an antibacterial effect against carbapenem-resistant Acinetobacter baumannii with synergism and additivity when combined with polymyxin B.
    Allend SO; Garcia MO; da Cunha KF; de Albernaz DTF; da Silva ME; Ishikame RY; Panagio LA; Nakazaro G; Reis GF; Pereira DB; Hartwig DD
    J Appl Microbiol; 2022 Feb; 132(2):1036-1047. PubMed ID: 34496109
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Palau M; Muñoz E; Gusta MF; Larrosa N; Gomis X; Gilabert J; Almirante B; Puntes V; Texidó R; Gavaldà J
    Microbiol Spectr; 2023 Jun; 11(3):e0028023. PubMed ID: 37078875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P; Kiratisin P
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Silver Nanoparticles in a Treatment Approach for Multidrug-Resistant
    Farouk MM; El-Molla A; Salib FA; Soliman YA; Shaalan M
    Int J Nanomedicine; 2020; 15():6993-7011. PubMed ID: 33061364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species.
    Kawamura-Sato K; Wachino J; Kondo T; Ito H; Arakawa Y
    J Antimicrob Chemother; 2010 Sep; 65(9):1975-83. PubMed ID: 20576639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009).
    Mendes RE; Farrell DJ; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):307-11. PubMed ID: 20955916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].
    Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P
    Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic resistance patterns in Acinetobacter spp. strains isolated from hospital environment].
    Văduva DB; Muntean D; Lonescu G; Licker M; Văduva MB; Velimirovici D; Rădulescu M; Dumitraşcu V; Crăciunescu M; Dugăeşescu D; Horhat F; Piluţ C; Bădiţoiu L; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):103-7. PubMed ID: 19856849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2.
    Tan TY; Ng LS; Poh K
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):357-61. PubMed ID: 17467946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.